NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $599,822 | +94.2% | 5,888 | +92.4% | 0.06% | +100.0% |
| Q2 2023 | $308,877 | +11.8% | 3,060 | +1.9% | 0.03% | +7.7% |
| Q1 2023 | $276,360 | -7.7% | 3,003 | -9.1% | 0.03% | -16.1% |
| Q4 2022 | $299,571 | -99.9% | 3,302 | -6.6% | 0.03% | +3.3% |
| Q3 2022 | $268,783,000 | -6.0% | 3,536 | +4.6% | 0.03% | -3.2% |
| Q2 2022 | $285,893,000 | -6.5% | 3,382 | -2.9% | 0.03% | +6.9% |
| Q1 2022 | $305,734,000 | +2.8% | 3,484 | +2.7% | 0.03% | +3.6% |
| Q4 2021 | $297,333,000 | -25.2% | 3,393 | -30.2% | 0.03% | -26.3% |
| Q3 2021 | $397,471,000 | +40.6% | 4,859 | +56.8% | 0.04% | +40.7% |
| Q2 2021 | $282,776,000 | +0.9% | 3,098 | -5.5% | 0.03% | -6.9% |
| Q1 2021 | $280,225,000 | -7.7% | 3,278 | +2.0% | 0.03% | -14.7% |
| Q4 2020 | $303,550,000 | +11.6% | 3,214 | +2.8% | 0.03% | 0.0% |
| Q3 2020 | $271,885,000 | -1.8% | 3,126 | -1.4% | 0.03% | -10.5% |
| Q2 2020 | $276,916,000 | +12.1% | 3,170 | +5.8% | 0.04% | -5.0% |
| Q1 2020 | $247,066,000 | -43.4% | 2,996 | -40.3% | 0.04% | -24.5% |
| Q3 2019 | $436,460,000 | -9.6% | 5,022 | -5.0% | 0.05% | -10.2% |
| Q2 2019 | $482,989,000 | +16.0% | 5,289 | +22.1% | 0.06% | +5.4% |
| Q1 2019 | $416,339,000 | +29.4% | 4,330 | +15.5% | 0.06% | +16.7% |
| Q4 2018 | $321,835,000 | +135.0% | 3,750 | +136.0% | 0.05% | +152.6% |
| Q3 2018 | $136,956,000 | +12.5% | 1,589 | -1.4% | 0.02% | +5.6% |
| Q2 2018 | $121,737,000 | +59575.0% | 1,612 | -36.0% | 0.02% | -43.8% |
| Q1 2018 | $204,000 | -3.3% | 2,519 | +0.4% | 0.03% | -11.1% |
| Q4 2017 | $211,000 | -21.6% | 2,510 | -30.8% | 0.04% | -20.0% |
| Q1 2017 | $269,000 | +18.5% | 3,626 | +16.1% | 0.04% | +7.1% |
| Q4 2016 | $227,000 | -26.8% | 3,122 | -20.6% | 0.04% | -30.0% |
| Q3 2016 | $310,000 | -7.5% | 3,932 | -3.1% | 0.06% | -4.8% |
| Q2 2016 | $335,000 | +6.7% | 4,057 | -6.5% | 0.06% | +3.3% |
| Q1 2016 | $314,000 | -21.7% | 4,338 | -6.9% | 0.06% | -27.4% |
| Q4 2015 | $401,000 | -20.4% | 4,659 | -15.1% | 0.08% | -26.3% |
| Q3 2015 | $504,000 | -3.8% | 5,485 | +3.0% | 0.11% | -5.0% |
| Q2 2015 | $524,000 | +8.5% | 5,327 | +8.8% | 0.12% | +9.1% |
| Q1 2015 | $483,000 | +9.8% | 4,895 | +3.0% | 0.11% | +115.7% |
| Q4 2014 | $440,000 | +0.9% | 4,753 | +2.6% | 0.05% | -50.5% |
| Q3 2014 | $436,000 | +4.6% | 4,633 | +0.6% | 0.10% | +3.0% |
| Q2 2014 | $417,000 | +17.5% | 4,606 | +10.4% | 0.10% | +4.2% |
| Q1 2014 | $355,000 | -27.3% | 4,173 | -31.3% | 0.10% | -35.1% |
| Q4 2013 | $488,000 | +3.4% | 6,076 | -1.2% | 0.15% | -3.3% |
| Q3 2013 | $472,000 | +0.6% | 6,147 | -7.4% | 0.15% | -6.1% |
| Q2 2013 | $469,000 | +2.0% | 6,636 | +2.8% | 0.16% | -1.2% |
| Q1 2013 | $460,000 | +38.1% | 6,453 | +22.8% | 0.16% | +24.1% |
| Q4 2012 | $333,000 | +9.5% | 5,253 | +6.0% | 0.13% | +18.8% |
| Q3 2012 | $304,000 | +3.4% | 4,956 | -5.8% | 0.11% | +15.5% |
| Q2 2012 | $294,000 | +41.3% | 5,260 | +44.8% | 0.10% | +44.8% |
| Q4 2011 | $208,000 | -52.9% | 3,632 | -59.1% | 0.07% | -83.0% |
| Q4 2008 | $442,000 | – | 8,885 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |